Hematopoietic stem cell transplantation does not increase the risk of infection-related complications for pediatric patients with Hodgkin and non-Hodgkin lymphomas: A multicenter nationwide study.
Olga Zajac-SpychalaJ WachowiakKrzysztof CzyŻewskiM DziedzicM WysockiP Zalas-WięcekA Szmydki-BaranŁ HutnikM MatysiakZ MałasW BadowskaO Gryniewicz-KwiatkowskaA GietkaB Dembowska-BagińskaK SemczukK Dzierżanowska-FangratM BartnikT OciepaT UrasińskiJ FrączkiewiczM SalamonowiczK KałwakE GorczyńskaA ChybickaN Irga-JaworskaE BieńE DrożyńskaL Chełmecka-WiktorczykW BalwierzI ZakF PierlejewskiW MłynarskiA Urbanek-DądelaG KarolczykW StolpaG Sobol-MilejskaM PłonowskiM Krawczuk-RybakJ MusiałR ChaberZ Gamrot-PykaM WoszczykR TomaszewskaT SzczepańskiJ KowalczykJan StyczyńskiPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
The incidence of IC was comparable during first- and second-line chemotherapy and after HSCT, but their profile was different for primary or re/ref lymphoma and depended on the type of therapy.